REUTERS
The U.S. Food and Drug Administration has granted an emergency use authorization for Moderna, Inc's COVID-19 vaccine, the second vaccine for the prevention of coronavirus disease 2019.
"The FDA statement came after the agency's vaccine advisory panel voted almost unanimously — 20 in favor, with one abstention — that the benefits of the highly effective vaccine outweighed its risks for people 18 years of age and older," The Washington Post wrote on December 18.
Read alsoUkraine has equipment for Pfizer, BioNTech vaccine – expert"Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older," the FDA said on its website on December 18.